Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease

Rowe, 2005, Mechanisms of disease, Cystic fibrosis, N Engl J Med, 352, 1992, 10.1056/NEJMra043184

Colombo, 2002, Liver disease in Cystic Fibrosis: a prospective study on incidence, risk factors and outcome, Hepatology, 36, 1374, 10.1053/jhep.2002.37136

Lindblad, 1999, Natural history of liver disease in Cystic Fibrosis, Hepatology, 30, 1151, 10.1002/hep.510300527

Debray, 1999, Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension, J Hepatol, 31, 77, 10.1016/S0168-8278(99)80166-4

Gooding, 2005, Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation, Liver Transpl, 12, 1522, 10.1002/lt.20465

Cystic Fibrosis Foundation, 2004

Colombo, 2004, Liver involvement in Cystic Fibrosis: primary organ damage or innocent bystander?, J Hepatol, 41, 1041, 10.1016/j.jhep.2004.10.002

Kelly D, Disease of the Liver and Biliary System in Children, Third edition, 2008.

Sokol, 1999, Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group, J Pediatr Gastroenterol Nutr, 28, 1, 10.1097/00005176-199900001-00001

Bartlett, 2009, Genetic modifiers of liver disease in cystic fibrosis, JAMA, 302, 1076, 10.1001/jama.2009.1295

Chen, 2005, Phosphatidyl-choline and lysophosphatidyl-choline excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine, Am J Clin Nutr, 81, 686, 10.1093/ajcn/81.3.686

Pinto, 2006, Non-alcoholic steatohepatitis from cell biology to clinical practice, J Hepatology, 44, 197, 10.1016/j.jhep.2005.09.002

Strandvik, 1988, Sclerosing cholangitis in cystic fibrosis, Scand J Gastroenterol Suppl, 143, 121, 10.3109/00365528809090231

Nagel, 1989, Liver disease and bile duct abnormalities in adults with cystic fibrosis, Lancet, 2, 1422, 10.1016/S0140-6736(89)92035-7

Durieu, 1999, Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study, J Hepatol, 30, 1052, 10.1016/S0168-8278(99)80259-1

Lindblad, 1992, Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis, Hepatology, 16, 372, 10.1002/hep.1840160215

Colombo, 1992, Ursodeoxycholic acid therapy in Cystic Fibrosis associated liver disease: a dose-response study, Hepatology, 16, 924, 10.1002/hep.1840160412

Colombo, 1992, Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with Cystic Fibrosis and associated liver disease, Hepatology, 15, 677, 10.1002/hep.1840150421

Colombo, 1996, Ursodeoxycholic acid for liver disease associated with Cystic Fibrosis: a double-blind multicenter trial, Hepatology, 23, 1484, 10.1002/hep.510230627

Lindblad, 1998, A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in Cystic Fibrosis, Hepatology, 23, 166, 10.1002/hep.510270126

Nousia-Arvanitakis, 2001, Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease, J Clin Gastroenterol, 32, 324, 10.1097/00004836-200104000-00009

Wilschanski, 1999, Clinical and genetic risk factors for CF-related liver disease, Pediatrics, 103, 52, 10.1542/peds.103.1.52

Lamireau, 2004, Epidemiology of liver disease in cystic fibrosis: a longitudinal study, J Hepatol, 41, 920, 10.1016/j.jhep.2004.08.006

Corbett, 2004, Cystic fibrosis-associated liver disease: a population-based study, J Pediatr, 145, 327, 10.1016/j.jpeds.2004.05.051

Potter, 1997, Can the histologie changes of Cystic Fibrosis-associated hepatobiliary disease be predicted by clinical criteria?, J Pediatr Gastroenterol Nutr, 25, 32, 10.1097/00005176-199707000-00005

Shapira, 1999, Retrospective review of cystic fibrosis presenting as infantile liver disease, Arch Dis Child, 81, 125, 10.1136/adc.81.2.125

Pereira, 2004, Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease, J Hepatol, 41, 576, 10.1016/j.jhep.2004.06.032

Patriquin, 1999, Liver disease in children with Cystic Fibrosis: US and biochemical comparison in 195 patients, Radiology, 211, 229, 10.1148/radiology.211.1.r99ap13229

Lenaerts, 2003, Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors, J Pediatr, 143, 343, 10.1067/S0022-3476(03)00329-9

Williams, 1995, An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis, J Hepatol, 22, 513, 10.1016/0168-8278(95)80444-7

Mueller-Abt, 2008, Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease, J Cyst Fibros, 7, 215, 10.1016/j.jcf.2007.08.001

de Lédinghen, 2007, Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy, J Pediatr Gastroenterol Nutr, 45, 443, 10.1097/MPG.0b013e31812e56ff

Foucher, 2006, Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study, Gut, 55, 403, 10.1136/gut.2005.069153

Witters, 2009, Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease, J Cyst Fibros, 8, 392, 10.1016/j.jcf.2009.08.001

O'Connor, 1996, The role of hepatobiliary scintigraphy in Cystic Fibrosis, Hepatology, 23, 281, 10.1002/hep.510230213

Lawson, 1978, Clinical estimation of liver span in infants and children, Am J Dis Child, 132, 474

Rosenberg, 1991, Normal splenic size in infants and children: sonographic measurements, AJR, 157, 119, 10.2214/ajr.157.1.2048509

Cheng K, Ashby D, Smyth R. Ursodeoxycholic acid for Cystic Fibrosis-related liver disease (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software 6-12, 2000.

Colombo, 1983, Evaluation of an ursodeoxycholic acid oral load in the assessment of bile acid malabsorption in Cystic Fibrosis, Dig Dis Sci, 28, 306, 10.1007/BF01324946

Rodríguez-Roisin, 2008, Hepatopulmonary syndrome: a liver-induced lung vascular disorder, N Engl J Med, 358, 2378, 10.1056/NEJMra0707185

Herve, 2007, Pulmonary vascular abnormalities in cirrhosis, Best Pract Res Clin Gastroenterol, 21, 141, 10.1016/j.bpg.2006.07.011

McKeon, 2004, Hepatocellular carcinoma in association with cirrhosis in a patient with Cystic Fibrosis, J Cyst Fibros, 3, 193, 10.1016/j.jcf.2004.04.006

Kelleher, 2005, Advanced hepatocellular carcinoma associated with Cystic Fibrosis, Eur J Gastroenterol Hepatol, 17, 1123, 10.1097/00042737-200510000-00018

de Franchis, 2005, Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 43, 167, 10.1016/j.jhep.2005.05.009

Khuroo, 2005, Meta-analysis: endoscopie variceal ligation for primary prophylaxis of oesophageal variceal bleeding, Aliment Pharmacol Ther, 21, 347, 10.1111/j.1365-2036.2005.02346.x

Pozler, 2003, Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results, Hepatogastroenterology, 50, 1111

Efrati, 2003, Liver cirrhosis and portal hypertension in Cystic Fibrosis, Eur J Gastroenterol Hepatol, 15, 1073, 10.1097/00042737-200310000-00002

Louis, 2007, Partial splenectomy for portal hypertension in cystic fibrosis related liver disease, Pediatr Pulmonol, 42, 1173, 10.1002/ppul.20713

Linnane, 2006, Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series, Arch Dis Child, 91, 771, 10.1136/adc.2006.093773

Robberecht, 2006, Outcome of total splenectomy with portosystemic shunt for massive splenomegaly and variceal bleeding in cystic fibrosis, J Pediatr Surg, 41, 1561, 10.1016/j.jpedsurg.2006.05.006

Minicucci, 2007, Liver disease as risk factor for cystic fibrosis-related diabetes development, Acta Paediatr, 96, 736, 10.1111/j.1651-2227.2007.00250.x

Noble-Jamieson, 1996, Liver transplantation for hepatic cirrhosis in cystic fibrosis, J Royal Soc Med, 89, 31

Milkiewicz, 2002, Transplantation for cystic fibrosis: outcome following early liver transplantation, J Gastroenterol Hepatol, 17, 208, 10.1046/j.1440-1746.2002.02671.x

Couetil, 1997, Combined heart-lung-liver, double lung-liver and isolated liver transplantation for cystic fibrosis in children, Transpl Int, 10, 33, 10.1111/j.1432-2277.1997.tb00533.x

Fridell, 2003, Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience, J Pediatr Surg, 38, 1152, 10.1016/S0022-3468(03)00260-4

Melzi, 2006, Liver transplant in Cystic Fibrosis: a poll among European centers. A study from the European Liver Transplant Registry, Transpl Int, 19, 726, 10.1111/j.1432-2277.2006.00344.x

Nash, 2008, Cystic fibrosis liver disease: to transplant or not to transplant?, Am J Transplant, 8, 162, 10.1111/j.1600-6143.2007.02028.x

Colombo, 2005, Effects of liver transplantation on the nutritional status of patients with Cystic Fibrosis, Transpl Int, 18, 246, 10.1111/j.1432-2277.2004.00013.x

Moyer, 2009, Hepatobiliary disease in patients with cystic fibrosis, Curr Opin Gastroenterol, 25, 272, 10.1097/MOG.0b013e3283298865